Safety and Efficacy of a Topical Cream in Mild-to-Moderate Seborrheic Dermatitis

Inclusion Criteria: * Age: 20-55 years (both inclusive) at the time of consent. * Sex: Males and non-pregnant/non-lactating females (preferably equal number of males and females). * Females of childbearing potential must have a self-reported negative urine pregnancy. * Subject is in good general health as determined by the Investigator on the basis of medical history. * Patients must have a confirmed diagnosis of mild to moderate scalp seborrheic dermatitis, with an ASFS score of at least 16 at the time of screening. * The severity grade will be evaluated by the dermatologist using the ASFS scale during the clinical study. * Subject is able to remain on stable doses of contraceptive or replacement hormonal therapy, including no therapy, 6 weeks prior to and for the duration of the study. * If the subject is of childbearing potential, is practicing and agrees to maintain an established method of birth control (IUD, hormonal implant device/injection, regular use of birth control pills or patch, diaphragm, condoms with spermicide or sponge with spermicidal jelly, cream or foam, partner vasectomy or abstinence). Females will be considered as non-childbearing potential if they are surgically sterile, have been post-menopausal for at least 1 year or have had a tubal ligation. * Patients are willing to give written informed consent and are willing to follow the study procedure. * Patients who commit not to use any other medicated/ prescription shampoos/hair care products, any other…